A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma

BACKGROUND: The therapeutic effect of immune checkpoint blockers, especially the neutralizing antibodies of programmed cell death (PD-1) and its ligand programmed death ligand 1 (PD-L1), has been well verified in melanoma. Nevertheless, the dissatisfactory response rate and the occurrence of resista...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunother Cancer
Main Authors: Guo, Weinan, Ma, Jinyuan, Guo, Sen, Wang, Huina, Wang, Sijia, Shi, Qiong, Liu, Lin, Zhao, Tao, Yang, Fengfan, Chen, Shuyang, Chen, Jianru, Zhao, Jianhong, Yu, Chen, Yi, Xiuli, Yang, Yuqi, Ma, Jingjing, Ni, Qingrong, Zhu, Guannan, Gao, Tianwen, Li, Chunying
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Basic Tumor Immunology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7733187/
https://ncbi.nlm.nih.gov/pubmed/33298620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001866
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki